102 related articles for article (PubMed ID: 325650)
1. Intravenous naloxone administration in schizophrenia and affective illness.
Davis GC; Bunney WE; DeFraites EG; Kleinman JE; van Kammen DP; Post RM; Wyatt RJ
Science; 1977 Jul; 197(4298):74-7. PubMed ID: 325650
[TBL] [Abstract][Full Text] [Related]
2. The effects of naloxone in chronic schizophrenia.
Berger PA; Watson SJ; Akil H; Barchas JD
Am J Psychiatry; 1981 Jul; 138(7):913-8. PubMed ID: 6266259
[TBL] [Abstract][Full Text] [Related]
3. The treatment of perceptual disturbances in schizophrenia with naloxone hydrochloride.
Kurland AA; McCabe OL; Hanlon TE; Sullivan D
Am J Psychiatry; 1977 Dec; 134(12):1408-10. PubMed ID: 335903
[TBL] [Abstract][Full Text] [Related]
4. Effects of naloxone on schizophrenia: reduction in hallucinations in a subpopulation of subjects.
Watson SJ; Berger PA; Akil H; Mills MJ; Barchas JD
Science; 1978 Jul; 201(4350):73-6. PubMed ID: 351804
[TBL] [Abstract][Full Text] [Related]
5. Negative naloxone effects in schizophrenic patients.
Janowsky DS; Segal DS; Abrams A; Bloom F; Guillemin R
Psychopharmacology (Berl); 1977 Aug; 53(3):295-7. PubMed ID: 19807
[TBL] [Abstract][Full Text] [Related]
6. Indication of an antipsychotic action of the opiate antagonist naloxone.
Emrich HM; Cording C; Pirée S; Kölling A; von Zerssen D; Herz A
Pharmakopsychiatr Neuropsychopharmakol; 1977 Sep; 10(5):265-70. PubMed ID: 30101
[TBL] [Abstract][Full Text] [Related]
7. Repeated naloxone administration in schizophrenia.
Verhoeven WM; van Praag HM; van Ree JM
Psychiatry Res; 1984 Aug; 12(4):297-312. PubMed ID: 6594713
[TBL] [Abstract][Full Text] [Related]
8. Lack of effect of naloxone and schizophrenic auditory hallucinations.
Freeman CP; Fairburn CG
Psychol Med; 1981 May; 11(2):405-7. PubMed ID: 7022531
[No Abstract] [Full Text] [Related]
9. Naloxone in chronic schizophrenia.
Volavka J; Mallya A; Baig S; Perez-Cruet J
Science; 1977 Jun; 196(4295):1227-8. PubMed ID: 860138
[TBL] [Abstract][Full Text] [Related]
10. Short-term naloxone administration in schizophrenic and manic patients. A World Health Organization Collaborative Study.
Pickar D; Vartanian F; Bunney WE; Maier HP; Gastpar MT; Prakash R; Sethi BB; Lideman R; Belyaev BS; Tsutsulkovskaja MV; Jungkunz G; Nedopil N; Verhoeven W; van Praag H
Arch Gen Psychiatry; 1982 Mar; 39(3):313-9. PubMed ID: 6121545
[TBL] [Abstract][Full Text] [Related]
11. Use of naloxone in schizophrenic psychoses and manic syndromes.
Verhoeven WM; van Praag HM; de Jong JT
Neuropsychobiology; 1981; 7(3):159-68. PubMed ID: 7231653
[TBL] [Abstract][Full Text] [Related]
12. A study of naloxone with schizophrenic and manic patients.
Sethi BB; Prakash R
Br J Psychiatry; 1981 Jun; 138():501-3. PubMed ID: 7028200
[TBL] [Abstract][Full Text] [Related]
13. Naloxone in schizophrenia.
Skrabanek P
Lancet; 1982 Dec; 2(8310):1270. PubMed ID: 6128561
[No Abstract] [Full Text] [Related]
14. Effect of naloxone on the state of patients with endogenous psychoses.
Lideman RR; Panteleeva GP; Tsutsul'kovskaya MYa ; Vartanyan FE; Belyaev BS
Neurosci Behav Physiol; 1984; 14(6):471-5. PubMed ID: 6097836
[No Abstract] [Full Text] [Related]
15. [Administration of naloxone in schizophrenic psychoses and manic syndromes].
Verhoeven WM; van Praag HM; de Jong JT
Ned Tijdschr Geneeskd; 1981 Apr; 125(14):532-7. PubMed ID: 6112715
[No Abstract] [Full Text] [Related]
16. Naloxone-induced reversal of schizophrenic hallucinations.
Gunne LM; Lindström L; Terenius L
J Neural Transm; 1977; 40(1):13-9. PubMed ID: 319204
[TBL] [Abstract][Full Text] [Related]
17. Lack of effect on naloxone on schizophrenic symptoms.
Janowsky DS; Segal DS; Bloom F; Abrams A; Guillemin R
Am J Psychiatry; 1977 Aug; 134(8):926-7. PubMed ID: 879360
[No Abstract] [Full Text] [Related]
18. Naloxone in chronic schizophrenic patients: neuroendocrine and behavioral effects.
Kleinman JE; Weinberger DR; Rogol A; Shiling DJ; Mendelson WB; Davis GC; Bunney WE; Wyatt RJ
Psychiatry Res; 1982 Aug; 7(1):1-7. PubMed ID: 6127744
[TBL] [Abstract][Full Text] [Related]
19. beta-Endorphin and naloxone in psychiatric patients: clinical and biological effects.
Lehmann H; Nair NP; Kline NS
Am J Psychiatry; 1979 Jun; 136(6):762-6. PubMed ID: 220889
[TBL] [Abstract][Full Text] [Related]
20. High-dose naloxone administration in chronic schizophrenia.
Cohen MR; Pickar D; Cohen RM
Biol Psychiatry; 1985 May; 20(5):573-5. PubMed ID: 3886025
[No Abstract] [Full Text] [Related]
[Next] [New Search]
